140 Intracoastal Pointe Drive, Suite 404
Jupiter, Florida 33477-5094 USA
C1 Technology Solutions
Enable rapid gene discovery. Accelerate product development. Bring gene products to market faster. Dyadic’s proprietary C1 technology is used for gene discovery, host optimization, large-scale manufacturing, and the creation of new products for diverse markets such as animal feed, pulp and paper, food, beverages, textiles, biofuels, biochemicals and biopharmaceuticals.
Develop advanced dependable bioenergy solutions. Identify novel enzymes that convert biomass into fermentable sugars for use in producing biofuels. Bring more cost-effective alternative fuel solutions to market faster. Dyadic’s C1 technology creates new development opportunities, through licensing arrangements and partnerships.
Break the bottlenecks in your genomic research and development programs. Accelerate product development. Improve production yields. Dyadic is interested in forming strategic partnerships to discover biomaterials, lower your costs, develop new products and bring them to market quickly.
Go from gene discovery to commercial manufacturing using the same host microorganism. Use Dyadic enzymes for large-scale production of innovative products. Dyadic delivers the C1 platform technology and more than 50 enzyme products to customers worldwide.
Welcome to Dyadic. We are a global biotechnology company with patented and proprietary technologies that are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. Dyadic leverages the value of its technologies through licensing arrangements and other collaborations with third parties who receive the benefits of producing and using the proteins these technologies help produce. LEARN MORE
August 18, 2014
Dyadic Files Form 10 Registration Statement Click Here Form 10 Registration Statement Click Here
August 14, 2014
Dyadic Reports Q2 2014 Financial Results Click Here
Conference Call Replay
August 5, 2014
Dyadic and CIMV Enter Into Collaboration Click Here
July 30, 2014
Thomas Dubinski Joins Dyadic as Chief Financial Officer Click Here
November 16 - 21, 2014
Dyadic's Chief Operating Officer Danai Brooks attends 14 AIChE Annual Meeting in Atlanta, GA Click Here
December 7 - 9, 2014
Dyadic's Chief Operating Officer Danai Brooks attends Bio Pacific Rim Summit on Industrial Biotechnology and Bioenergy in San Diego, CA Click Here
Mark Emalfarb Interview at LD Micro VI Los Angeles, December 3-5, 2013